We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Bangladesh-based Beximco Pharmaceuticals has become the first company to launch a generic version of Gilead Sciences’ remdesivir for treating COVID-19. Read More
The FDA slapped an Aquebogue, New York drug manufacturer with a warning letter over serious data integrity lapses and violations related to environmental and personnel monitoring. Read More
Another study — the largest to date — has shown that anti-malaria drugs hydroxychloroquine and chloroquine have no benefit in treating COVID-19, in fact have a negative effect on patient survival and are associated with an increase in ventricular arrhythmias. Read More
President Trump says he wants drug pricing legislation passed this year despite the coronavirus pandemic, according to Sen. Chuck Grassley (R-Iowa), the chairman of the Senate Finance Committee. Read More